8-143213279-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_178172.6(GPIHBP1):c.12C>T(p.Leu4Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.179 in 1,594,926 control chromosomes in the GnomAD database, including 27,137 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 2089 hom., cov: 33)
Exomes 𝑓: 0.18 ( 25048 hom. )
Consequence
GPIHBP1
NM_178172.6 synonymous
NM_178172.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.02
Genes affected
GPIHBP1 (HGNC:24945): (glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1) This gene encodes a capillary endothelial cell protein that facilitates the lipolytic processing of triglyceride-rich lipoproteins. The encoded protein is a glycosylphosphatidylinositol-anchored protein that is a member of the lymphocyte antigen 6 (Ly6) family. This protein plays a major role in transporting lipoprotein lipase (LPL) from the subendothelial spaces to the capillary lumen. Mutations in this gene are the cause of hyperlipoproteinemia, type 1D. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 8-143213279-C-T is Benign according to our data. Variant chr8-143213279-C-T is described in ClinVar as [Benign]. Clinvar id is 1287705.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-143213279-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-4.02 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.184 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPIHBP1 | NM_178172.6 | c.12C>T | p.Leu4Leu | synonymous_variant | 1/4 | ENST00000622500.2 | NP_835466.2 | |
GPIHBP1 | NM_001301772.2 | c.12C>T | p.Leu4Leu | synonymous_variant | 1/5 | NP_001288701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPIHBP1 | ENST00000622500.2 | c.12C>T | p.Leu4Leu | synonymous_variant | 1/4 | 1 | NM_178172.6 | ENSP00000480053.1 |
Frequencies
GnomAD3 genomes AF: 0.151 AC: 22923AN: 152012Hom.: 2091 Cov.: 33
GnomAD3 genomes
AF:
AC:
22923
AN:
152012
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.182 AC: 40211AN: 220506Hom.: 3874 AF XY: 0.181 AC XY: 21656AN XY: 119352
GnomAD3 exomes
AF:
AC:
40211
AN:
220506
Hom.:
AF XY:
AC XY:
21656
AN XY:
119352
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.182 AC: 263251AN: 1442796Hom.: 25048 Cov.: 31 AF XY: 0.182 AC XY: 130682AN XY: 716480
GnomAD4 exome
AF:
AC:
263251
AN:
1442796
Hom.:
Cov.:
31
AF XY:
AC XY:
130682
AN XY:
716480
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.151 AC: 22918AN: 152130Hom.: 2089 Cov.: 33 AF XY: 0.154 AC XY: 11449AN XY: 74366
GnomAD4 genome
AF:
AC:
22918
AN:
152130
Hom.:
Cov.:
33
AF XY:
AC XY:
11449
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
603
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 30, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2019 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at